Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Minocycline and autoimmunity.

A H Eichenfield1

  • 1Division of Pediatric Rheumatology, Mount Sinai School of Medicine, New York, New York 10029-6574, USA.

Current Opinion in Pediatrics
|November 11, 1999
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Cell-bound complement activation products (CB-CAPs) have high sensitivity and specificity in pediatric-onset systemic lupus erythematosus and correlate with disease activity.

Lupus·2018
Same author

Early versus later onset childhood-onset systemic lupus erythematosus: Clinical features, treatment and outcome.

Lupus·2011
Same author

Comparative value of urinalysis, urine cytology and urine sIL2R in the assessment of renal disease in patients with systemic lupus erythematosus (SLE).

Clinical nephrology·1996
Same author

Successful treatment of severe cytophagic histiocytic panniculitis with cyclosporine A.

Seminars in arthritis and rheumatism·1996
Same author

Recurrent reflex sympathetic dystrophy as a manifestation of systemic lupus erythematosus.

The Journal of rheumatology·1993
Same author

Atypical arthropathy associated with Crohn's disease.

The American journal of gastroenterology·1993
Same journal

For health, for beauty, or both? navigating trends as adolescent clinicians.

Current opinion in pediatrics·2026
Same journal

Childhood sleep disorders: practical management for the pediatrician.

Current opinion in pediatrics·2026
Same journal

Advanced therapies in management of pediatric inflammatory bowel disease.

Current opinion in pediatrics·2026
Same journal

Artificial intelligence in pediatric endoscopy for hereditary polyposis syndromes: promises and challenges.

Current opinion in pediatrics·2026
Same journal

Hormonal acne therapies in pediatrics.

Current opinion in pediatrics·2026
Same journal

Clinical implementation of artificial intelligence in adolescent mental healthcare.

Current opinion in pediatrics·2026
See all related articles

Minocycline, an acne antibiotic, shows anti-inflammatory effects beneficial for rheumatoid arthritis. However, it can also trigger autoimmune reactions like lupus and hepatitis.

Area of Science:

  • Immunology
  • Pharmacology
  • Rheumatology

Background:

  • Minocycline is a common antibiotic for acne treatment.
  • Emerging research highlights its anti-inflammatory and immunomodulatory properties.
  • Concerns exist regarding minocycline-induced autoimmune adverse reactions.

Purpose of the Study:

  • To review evidence of minocycline's anti-inflammatory and immunomodulatory effects.
  • To assess its efficacy in treating rheumatoid arthritis.
  • To summarize adverse autoimmune reactions associated with minocycline use.

Main Methods:

  • Literature review of studies on minocycline.
  • Analysis of clinical evidence for anti-inflammatory and immunomodulatory actions.
  • Compilation of reported autoimmune adverse events.

Related Experiment Videos

Main Results:

  • Minocycline exhibits significant anti-inflammatory and immunomodulatory capabilities.
  • Evidence supports its utility in managing rheumatoid arthritis symptoms.
  • Reported adverse reactions include serum sickness-like disease, drug-induced lupus, and autoimmune hepatitis.

Conclusions:

  • Minocycline possesses therapeutic potential beyond acne treatment due to its immune-modulating effects.
  • Careful monitoring for autoimmune adverse events is crucial in patients treated with minocycline.
  • The drug's dual action necessitates a balanced consideration of benefits and risks.